Health Condition 1: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Intervention1: Magnesium hydroxide tablet with 200mg elemental
magnesium: Tablet Magnesium hydroxide 200mg ,
Frequency :Two times a day
Route of administration : Oral
Duration : 3 Months
Control Inte
Sponsors
Dr Dhaval Dalal
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient of age 18 years to 80 years and who are willing to participate and sign informed consent form. 2. Previously diagnosed cases of type 2 diabetes mellitus as per the ADA criteria ; both male and female. 3. Patient on standard line of treatment as per ADA guidelines. 4.HbA1c 6.5 to 9.
Exclusion criteria
Exclusion criteria: 1. Pregnant Women and or Breast feeding patients. 2. Patient with egfr less than or equal to 60. 3. Patient suffering from inflammatory bowel disease, malabsorption syndromes. 4. Patients suffering from malignancy, severe infectious disease, immunosuppressive state, chronic liver disease, steroids. 5. Patients with history of bariatric surgery, alcoholism, hyperthyroidism, recent gastroenteritis, recent major lifestyle change including strenuous exercise (working out). 6. Patient with iron deficiency anaemia (Hb less than 10 g/dl).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. HbA1c 2. Change in fasting plasma glucose at baseline and at 12 weeks ( Baseline and 12 weeks) Timepoint: At baseline, 1 month and at 3 months | — |
Secondary
| Measure | Time frame |
|---|---|
| To study incidence of documented magnesium deficiency among diabetic patients attending OPDTimepoint: At baseline , 4 weeks and week 12 | — |
Countries
India
Contacts
Public ContactDr Vijaykumar Gawali
Bhaktivedanta Hospital and Research Institute
Outcome results
None listed